(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EVIDENCE EVOLUTION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EVIDENCE EVOLUTION

ST13

US500000085094857

Class

1, 5, 9, 10

Filing

85094857

Registration

4037239

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/31/2025

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

07/28/2010

Registration date

10/11/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/08/2022

Last transaction

12/31/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

07/27/2010

First use in commerce

07/27/2010

Drawing code

4

Owner type

99

Owner location

Antrim, GB

Examiner

VANSTON, KATHY

Law office

L70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Randox Laboratories Ltd
Randox Laboratories Ltd

Representatives

Timothy M. Kenny NORTON ROSE FULBRIGHT US LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations for scientific purposes; chemical reagents for scientific purposes; enzymes and proteins for use in scientific and medical research applications; clinical diagnostic preparations for scientific purposes; diagnostic scanning agents for scientific and research use; diagnostic testing agentspreparations and substances for scientific and research purposes

Class 5

Medicated sera for use in diagnostic preparations for diagnosis of diseases and disease states; anti-sera used in diagnostic reagents to assist in the detection of antigens or antibodies present in disease states; diagnostic preparations and substances for medical and veterinary purposes; kits for medical purposesdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; clinical diagnostic preparations for medical or veterinary use; clinical diagnostic reagents for in vitro and in vivo medical use; diagnostic scanning agents for in vivo medical use; diagnostic testing agentspreparations and substances for medical use; chemical reagents for medical diagnostics in the diagnosis of diseases and disease states

Class 9

Computer software for use in conjunction with in vitro diagnostic testing apparatussoftware to control sample handlingsample processingsample result reporting and test apparatus system robotics; clinical laboratory chemistry analyzers for use in measuring blood proteinsenzymesimmunoglobulinshormones and drugs; barcode scanners; printers

Class 10

Diagnostic testing apparatus and instruments for medical useprobes for use in in vitro diagnostic testing procedures; clinical chemistry analyzers for medical and veterinary diagnostictherapeutic and clinical usefor use in measuring blood proteinsenzymesimmunoglobulinshormonesdrugs; diagnostic testing apparatus for immunoassay proceduresfor use in the measurement of antibodiesimmunoglobulinshormones and drugs

Publications

History of USPTO decisions and trademark events.

38 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/29/2025

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

12/29/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/29/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/29/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/08/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/08/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/08/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/01/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

10/11/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/11/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/01/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/01/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/01/2017

E815

TEAS SECTION 8 & 15 RECEIVED

10/10/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

10/11/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/26/2011

PUBO

PUBLISHED FOR OPPOSITION

07/26/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/23/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/22/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/21/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/21/2011

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/21/2011

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/18/2011

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/26/2011

GNSL

LETTER OF SUSPENSION E-MAILED

05/26/2011

CNSL

SUSPENSION LETTER WRITTEN

05/26/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/19/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/19/2011

ALIE

ASSIGNED TO LIE

05/17/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/10/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/10/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/10/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/12/2010

GNRT

NON-FINAL ACTION E-MAILED

11/12/2010

CNRT

NON-FINAL ACTION WRITTEN

11/12/2010

DOCK

ASSIGNED TO EXAMINER

11/11/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/02/2010

NWAP

NEW APPLICATION ENTERED

07/31/2010

Continuous trademark protection

Get notified about every new filing that threatens EVIDENCE EVOLUTION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.